Bastiaan Driehuys
4 clinical trials · 4 recruiting · OTHER
Trials by Bastiaan Driehuys
RECRUITINGPhase 2NCT06104228
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
The overall study objectives outlined in this study are to derive 129Xe MRI pulmonary vascular biomarker signatures that differentiate common subtypes of PAH and to determine the...
Sponsor: Bastiaan DriehuysEnrolling: 201 location
Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)+1
RECRUITINGPhase 2NCT04991454
Xenon MRI Pulm Hypertension
The overall objective outlined in this study is to determine how pulmonary vascular remodeling in PAH at a cellular and pathological level is associated with changes in gas...
Sponsor: Bastiaan DriehuysEnrolling: 601 location
Pulmonary HypertensionPulmonary Arterial Hypertension
RECRUITINGPhase 2NCT06038630
129Xe MRI Cardiopulmonary
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
Sponsor: Bastiaan DriehuysEnrolling: 1251 location
Interstitial Lung DiseaseChronic Thromboembolic Pulmonary HypertensionAcute Pulmonary Embolism+3
RECRUITINGPhase 2NCT01280994
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI...
Sponsor: Bastiaan DriehuysEnrolling: 4451 location
Interstitial Lung Disease